CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea · Delayed Price · Currency is KRW 9,630.00
-660.00 (-6.41%)
At close: Aug 1, 2025, 3:30 PM KST
Sage Therapeutics Market Cap
CJ Bioscience has a market cap or net worth of 126.08 billion as of August 4, 2025. Its market cap has increased by 12.12% in one year.
Market Cap
126.08B
Enterprise Value
70.10B
Revenue
3.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
$9,630.00
Market Cap Chart
Since December 26, 2019, CJ Bioscience's market cap has decreased from 146.64B to 126.08B, a decrease of -14.02%. That is a compound annual growth rate of -2.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 126.08B | -4.36% |
| Dec 30, 2024 | 131.83B | -10.37% |
| Dec 28, 2023 | 147.08B | -13.73% |
| Dec 29, 2022 | 170.48B | -40.40% |
| Dec 30, 2021 | 286.05B | 43.53% |
| Dec 30, 2020 | 199.29B | 39.15% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 450.15T |
| SK hynix | 178.11T |
| LG Energy Solution | 87.28T |
| Samsung Biologics | 73.59T |
| Hanwha Aerospace | 48.31T |
| Hyundai Motor Company | 45.86T |
| HD Hyundai Heavy Industries | 42.30T |
| Doosan Enerbility | 39.32T |